Are There Gender Differences in Quality of Life and Symptomatology Between Fibromyalgia Patients?
The purpose of this study is to examine gender differences in quality of life (QoL) and symptomatology in fibromyalgia (FM) patients. A total of 20 men (48.0 ± 8.0 years) and 78 women (49.8 ± 7.2 years) with FM participated in the study (age range 31-63 years). Health-related QoL and FM impact were...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2012-07-01
|
Series: | American Journal of Men's Health |
Online Access: | https://doi.org/10.1177/1557988312436872 |
_version_ | 1818043008980877312 |
---|---|
author | Virginia A. Aparicio PhD Francisco B. Ortega PhD Ana Carbonell-Baeza PhD Pedro Femia PhD Pablo Tercedor PhD Jonatan R. Ruiz PhD Manuel Delgado-Fernández PhD |
author_facet | Virginia A. Aparicio PhD Francisco B. Ortega PhD Ana Carbonell-Baeza PhD Pedro Femia PhD Pablo Tercedor PhD Jonatan R. Ruiz PhD Manuel Delgado-Fernández PhD |
author_sort | Virginia A. Aparicio PhD |
collection | DOAJ |
description | The purpose of this study is to examine gender differences in quality of life (QoL) and symptomatology in fibromyalgia (FM) patients. A total of 20 men (48.0 ± 8.0 years) and 78 women (49.8 ± 7.2 years) with FM participated in the study (age range 31-63 years). Health-related QoL and FM impact were assessed by means of the Spanish versions of the Short-Form-36 Health Survey (SF36) and the Fibromyalgia Impact Questionnaire (FIQ), respectively. Comparisons in QoL were performed using one-way analysis of covariance adjusted by age and body mass index (BMI), and comparisons in FIQ dimensions were performed using Mann-Whitney test. Overall FM impact, as measured by FIQ-total score ( p = .01) and FIQ-physical impairment ( p = .02) was higher in men, whereas women presented higher values of FIQ-fatigue and FIQ-morning tiredness ( p = .04) and less SF36-vitality ( p = .02). Therefore, women appear to feel more fatigue, whereas men present higher FM overall impact. Due to the small number of men included in this study and the consequent small statistical power, these results should be taken as preliminary. Higher powered studies are warranted to further address gender differences in FM in order to design more successful treatments. |
first_indexed | 2024-12-10T08:55:23Z |
format | Article |
id | doaj.art-cd33b0b5476648278baf986a10a4dc4c |
institution | Directory Open Access Journal |
issn | 1557-9883 1557-9891 |
language | English |
last_indexed | 2024-12-10T08:55:23Z |
publishDate | 2012-07-01 |
publisher | SAGE Publishing |
record_format | Article |
series | American Journal of Men's Health |
spelling | doaj.art-cd33b0b5476648278baf986a10a4dc4c2022-12-22T01:55:27ZengSAGE PublishingAmerican Journal of Men's Health1557-98831557-98912012-07-01610.1177/1557988312436872Are There Gender Differences in Quality of Life and Symptomatology Between Fibromyalgia Patients?Virginia A. Aparicio PhD0Francisco B. Ortega PhD1Ana Carbonell-Baeza PhD2Pedro Femia PhD3Pablo Tercedor PhD4Jonatan R. Ruiz PhD5Manuel Delgado-Fernández PhD6Karolinska Institute, Stockholm, SwedenKarolinska Institute, Stockholm, SwedenUniversity of Cádiz, Cádiz, SpainUniversity of Granada, Granada, SpainUniversity of Granada, Granada, SpainKarolinska Institute, Stockholm, SwedenUniversity of Granada, Granada, SpainThe purpose of this study is to examine gender differences in quality of life (QoL) and symptomatology in fibromyalgia (FM) patients. A total of 20 men (48.0 ± 8.0 years) and 78 women (49.8 ± 7.2 years) with FM participated in the study (age range 31-63 years). Health-related QoL and FM impact were assessed by means of the Spanish versions of the Short-Form-36 Health Survey (SF36) and the Fibromyalgia Impact Questionnaire (FIQ), respectively. Comparisons in QoL were performed using one-way analysis of covariance adjusted by age and body mass index (BMI), and comparisons in FIQ dimensions were performed using Mann-Whitney test. Overall FM impact, as measured by FIQ-total score ( p = .01) and FIQ-physical impairment ( p = .02) was higher in men, whereas women presented higher values of FIQ-fatigue and FIQ-morning tiredness ( p = .04) and less SF36-vitality ( p = .02). Therefore, women appear to feel more fatigue, whereas men present higher FM overall impact. Due to the small number of men included in this study and the consequent small statistical power, these results should be taken as preliminary. Higher powered studies are warranted to further address gender differences in FM in order to design more successful treatments.https://doi.org/10.1177/1557988312436872 |
spellingShingle | Virginia A. Aparicio PhD Francisco B. Ortega PhD Ana Carbonell-Baeza PhD Pedro Femia PhD Pablo Tercedor PhD Jonatan R. Ruiz PhD Manuel Delgado-Fernández PhD Are There Gender Differences in Quality of Life and Symptomatology Between Fibromyalgia Patients? American Journal of Men's Health |
title | Are There Gender Differences in Quality of Life and Symptomatology Between Fibromyalgia Patients? |
title_full | Are There Gender Differences in Quality of Life and Symptomatology Between Fibromyalgia Patients? |
title_fullStr | Are There Gender Differences in Quality of Life and Symptomatology Between Fibromyalgia Patients? |
title_full_unstemmed | Are There Gender Differences in Quality of Life and Symptomatology Between Fibromyalgia Patients? |
title_short | Are There Gender Differences in Quality of Life and Symptomatology Between Fibromyalgia Patients? |
title_sort | are there gender differences in quality of life and symptomatology between fibromyalgia patients |
url | https://doi.org/10.1177/1557988312436872 |
work_keys_str_mv | AT virginiaaapariciophd aretheregenderdifferencesinqualityoflifeandsymptomatologybetweenfibromyalgiapatients AT franciscobortegaphd aretheregenderdifferencesinqualityoflifeandsymptomatologybetweenfibromyalgiapatients AT anacarbonellbaezaphd aretheregenderdifferencesinqualityoflifeandsymptomatologybetweenfibromyalgiapatients AT pedrofemiaphd aretheregenderdifferencesinqualityoflifeandsymptomatologybetweenfibromyalgiapatients AT pablotercedorphd aretheregenderdifferencesinqualityoflifeandsymptomatologybetweenfibromyalgiapatients AT jonatanrruizphd aretheregenderdifferencesinqualityoflifeandsymptomatologybetweenfibromyalgiapatients AT manueldelgadofernandezphd aretheregenderdifferencesinqualityoflifeandsymptomatologybetweenfibromyalgiapatients |